Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01223872 · ClinicalTrials.gov registry record
Childhood Cancer Survivors' Knowledge of Diagnosis,Treatment and Risk of Late Effects: Specialized Survivorship Clinic
A clinical trial of Childhood Cancer, sponsored by Vanderbilt University Medical Center.
- Completed
- Registry status
- 188
- Enrollment target
- 1
- Study location
NCT01223872: Completed study of Childhood Cancer, sponsored by Vanderbilt University Medical Center.
NCT01223872 is a study of Childhood Cancer that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 188 participants, below the 1,464-participant average among 23 other Childhood Cancer trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01223872, a study of Childhood Cancer, has completed, sponsored by Vanderbilt University Medical Center.
- COMPLETED
- Registry status
- 188 participants
- Enrollment target
- 1
- Study location
Study Summary
This two-part research study will compare childhood cancer survivors receiving specialized follow-up care in the REACH for Survivorship clinic to patients receiving routine follow-up care.
Primary Outcome
In addition to data from patient interviews, a review of medical records will include general patient demographic data as well as data regarding cancer diagnosis, treatment and ongoing follow-up care.
Conditions Studied
Interventions
- OTHER interview
- OTHER clinic visit and interview
- OTHER interviews and clinic visit
Study Locations (1)
Tennessee
- Vanderbilt-Ingram Cancer Center - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 188 participants |
| Start Date | 2010-08 |
| Est. Completion | 2015-08 |
What the finished NCT01223872 record still lists
NCT01223872 is an observational study that tracks outcomes without assigning an intervention. The registered 188 participants enrollment target is mid-sized for trials with a published cap, below the 1,464-participant average among 23 other Childhood Cancer trials with a reported enrollment target (87% lower).
The record links to 1 condition, with Childhood Cancer appearing as the primary indexed condition, and to 3 interventions - of which interview is the first listed.
NCT01223872 reports a single indexed study location in Tennessee.
Frequently Asked Questions
What is clinical trial NCT01223872 about?
NCT01223872 is a clinical study titled "Childhood Cancer Survivors' Knowledge of Diagnosis,Treatment and Risk of Late Effects: Specialized Survivorship Clinic". This two-part research study will compare childhood cancer survivors receiving specialized follow-up care in the REACH for Survivorship clinic to patients receiving routine follow-up care.
What is the current status of trial NCT01223872?
This trial is currently completed. The enrollment target is 188 participants. The study started on 2010-08. Estimated completion is 2015-08.
What conditions does trial NCT01223872 study?
This clinical trial studies the following conditions: Childhood Cancer.
What interventions are being tested in trial NCT01223872?
The interventions under investigation include: interview (OTHER), clinic visit and interview (OTHER), interviews and clinic visit (OTHER).
Who is sponsoring clinical trial NCT01223872?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01223872 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Childhood Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01223872's enrollment target sits among peer trials
188 6th of 23 higher than 17 of 23 other Childhood Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Childhood Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Preparing for Life and Academics for Young Childhood Cancer Survivors
RECRUITING · NA
-
Assessment of Remote Approaches for Identification of Autonomic Dysfunction Among Survivors of Leukemia and Lymphoma
RECRUITING · NA
-
Patients At Risk for Sensory Screening (HPARSS) to Enhance Sensory Deficit Screening in Childhood Cancer Survivors
RECRUITING · NA
-
Light Therapy for Chemotherapy Induced Peripheral Neuropathy in Childhood Cancer Survivors
RECRUITING · NA
-
Mobile App to Help Survivors of Childhood Cancer Navigate Long-Term Follow-Up Care
RECRUITING · NA
-
Proof-of-Concept Testing of the Cardiovascular Health Equity Through Food (CHEF) Intervention in Childhood Cancer Survivors
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03422198 · 188 participants · Phase 3
Short Course Vaginal Cuff Brachytherapy in Treating Participants With Stage I-II Endometrial Cancer
- NCT04469790 · 188 participants · NA
Effects of Multi-day Interruptions in Sitting on Type 2 Diabetes-relevant Outcomes in Children
- NCT04671667 · 188 participants · Phase 2
Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma
- NCT04853251 · 188 participants · Phase 4
A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia